Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/15/24 16:05 | 11/13/24 | VCEL | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | D | 1 | S.d | -389 | 55.54 | 0 | -7 | 12 | D | ||||||||||||||||
11/15/24 16:05 | 11/13/24 | VCEL | Health | BioPrd | Biological Products, (No Diag | Colangelo Dominick | MA | DO | P,CEO | 3 | S.dm | -4,874 | 46.42 | 0 | -105 | 221 | D | |||||||||||||||
11/13/24 16:05 | 11/11/24 | VCEL | Health | BioPrd | Biological Products, (No Diag | Zerbe Robert L Md | MA | D | 1 | S.dm | -281 | 56.25 | 0 | -5 | 27 | D | ||||||||||||||||
10/18/24 16:05 | 10/16/24 | VCEL | Health | BioPrd | Biological Products, (No Diag | Gilman Steven C | MA | D | 4 | S.d | -985 | 43.79 | 0 | -23 | 11 | D | ||||||||||||||||
10/2/24 16:06 | 10/1/24 | VCEL | Health | BioPrd | Biological Products, (No Diag | Siegal Jonathan | MA | O | Principa | 1 | S.d | -24 | 41.90 | 0 | -1 | 1 | D | |||||||||||||||
9/5/24 16:05 | 9/3/24 | VCEL | Health | BioPrd | Biological Products, (No Diag | Hopper Jonathan Mark | MA | O | Chief Me | 1 | S.d | -498 | 49.83 | 0 | -10 | 58 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |